AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇲
Irinotecan Hydrochloride Trihydrate in Zambia
4 products registered with ZAMRA — 4 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| Irocan 300 Injection Concentrate for solution for infusion | 376/028 | Innovata Pharmaceuticals (Pty) Ltd | active | 11 Jul 2030 |
| Irocan 100 Injection Concentrate for solution for infusion | 376/027 | Innovata Pharmaceuticals (Pty) Ltd | active | 11 Jul 2030 |
| Irocan 500 injection Concentrate for solution for infusion | 376/029 | Innovata Pharmaceuticals (Pty) Ltd | active | 19 Mar 2030 |
| Irocan 40 Injection Concentrate for solution for infusion | 376/026 | Innovata Pharmaceuticals (Pty) Ltd | active | 19 Mar 2030 |
Irinotecan Hydrochloride Trihydrate — ZAMRA Registration Details
ZAMRA (Zambia) has 4 registered products containing Irinotecan Hydrochloride Trihydrate, of which 4 are currently active. Data is sourced directly from the official ZAMRA drug register and refreshed daily.
Track Irinotecan Hydrochloride Trihydrate registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.